MintNeuro and Motif Neurotech Partner to Advance Miniature Brain-Computer Interface Therapy
Summary
MintNeuro, a semiconductor company focused on neural implant integrated circuits, announced a partnership with Motif Neurotech to advance miniature brain-computer interface therapy for mental health. MintNeuro designs purpose-built, low-power sensing and stimulation ICs that enable medical device developers to build smaller, smarter implantable systems. The partnership combines MintNeuro's chip technology with Motif's therapeutic BCI platform.
Why it matters
This partnership addresses a critical technical challenge in the BCI field: miniaturization of implantable neural devices. By combining MintNeuro's semiconductor expertise with Motif's therapeutic BCI platform, the companies aim to create smaller, more capable implantable systems for treating neurological and psychiatric conditions. The collaboration could accelerate development of next-generation BCI devices that are less invasive and more accessible to patients.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial